Bharat Biotech’s new variant of vaccine gets WHO pre-qualification
The Hindu
Low dose volume of Rotavac 5D delivers multiple benefits
Bharat Biotech on Monday said rotavirus vaccine Rotavac 5D has received World Health Organisation’s (WHO) pre-qualification, a development that is expected to fast-track procurement and global access of the new variant of Rotavac. “WHO pre-qualification enables the procurement of Rotavac 5D by UNICEF and PAHO... will fast-track global access to this life saving vaccine. It is a validation of the global quality and safety standards required for paediatric vaccines,” the vaccine maker said in a statement. Used for prevention of rotavirus infection, which is a cause of severe diarrhoea and prevalent in infants and young children, the low dose volume (0.5 mL) of Rotavac 5D facilitates easy logistics, cold chain management and low biomedical waste disposal post-vaccination. The new variant is a unique rotavirus vaccine formulation that can be administered without a buffer, Bharat Biotech said.More Related News